298 related articles for article (PubMed ID: 20350910)
21. [Bone remodeling: new therapeutic approaches].
Ferrari S
Rev Med Suisse; 2009 Jun; 5(207):1325-8. PubMed ID: 19626933
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)].
Quemerais-Durieu MA; Kerlan V; Chabre O
Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272
[TBL] [Abstract][Full Text] [Related]
23. New developments in the treatment of osteoporosis.
Eriksen EF; Halse J; Moen MH
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):620-36. PubMed ID: 22646526
[TBL] [Abstract][Full Text] [Related]
24. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development.
Li H; Xiao Z; Quarles LD; Li W
Curr Med Chem; 2021; 28(8):1489-1507. PubMed ID: 32223730
[TBL] [Abstract][Full Text] [Related]
25. Developments in the pharmacotherapeutic management of osteoporosis.
Close P; Neuprez A; Reginster JY
Expert Opin Pharmacother; 2006 Aug; 7(12):1603-15. PubMed ID: 16872263
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy.
Mukherjee K; Chattopadhyay N
Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079
[TBL] [Abstract][Full Text] [Related]
27. Update in new anabolic therapies for osteoporosis.
Canalis E
J Clin Endocrinol Metab; 2010 Apr; 95(4):1496-504. PubMed ID: 20375217
[TBL] [Abstract][Full Text] [Related]
28. Anabolic Agents for Osteoporosis : What is Their Likely Place in Therapy?
Girotra M; Rubin MR; Bilezikian JP
Treat Endocrinol; 2006; 5(6):347-58. PubMed ID: 17107220
[TBL] [Abstract][Full Text] [Related]
29. Current and emerging therapies for the treatment of osteoporosis.
Waalen J
J Exp Pharmacol; 2010; 2():121-34. PubMed ID: 27186098
[TBL] [Abstract][Full Text] [Related]
30. New targets for intervention in the treatment of postmenopausal osteoporosis.
Lewiecki EM
Nat Rev Rheumatol; 2011 Sep; 7(11):631-8. PubMed ID: 21931340
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
Palacios S
Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
[TBL] [Abstract][Full Text] [Related]
32. The future of osteoporosis treatment - a research update.
Lippuner K
Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185
[TBL] [Abstract][Full Text] [Related]
33. Anabolic therapies for osteoporosis.
Uihlein AV; Leder BZ
Endocrinol Metab Clin North Am; 2012 Sep; 41(3):507-25. PubMed ID: 22877427
[TBL] [Abstract][Full Text] [Related]
34. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
35. [Advances treatment of osteoporosis: new molecules, new strategies].
Orcel P
Bull Acad Natl Med; 2010 Nov; 194(8):1505-16; discussion 1516-8. PubMed ID: 22046713
[TBL] [Abstract][Full Text] [Related]
36. New therapeutics for osteoporosis.
Ng KW; Martin TJ
Curr Opin Pharmacol; 2014 Jun; 16():58-63. PubMed ID: 24699340
[TBL] [Abstract][Full Text] [Related]
37. Perspectives on osteoporosis therapies.
Cairoli E; Zhukouskaya VV; Eller-Vainicher C; Chiodini I
J Endocrinol Invest; 2015 Mar; 38(3):303-11. PubMed ID: 25577263
[TBL] [Abstract][Full Text] [Related]
38. Future developments in osteoporosis therapy.
Ng KW
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):371-84. PubMed ID: 19857200
[TBL] [Abstract][Full Text] [Related]
39. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
Epstein S
Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
[TBL] [Abstract][Full Text] [Related]
40. Mathematical Model of Bone Remodeling Captures the Antiresorptive and Anabolic Actions of Various Therapies.
Ross DS; Mehta K; Cabal A
Bull Math Biol; 2017 Jan; 79(1):117-142. PubMed ID: 27905067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
